4//SEC Filing
Spragens Jeffrey G 4
Accession 0001209191-22-060442
CIK 0001833214other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 9:02 AM ET
Size
7.5 KB
Accession
0001209191-22-060442
Insider Transaction Report
Form 4
Spragens Jeffrey G
Director
Transactions
- Award
Warrant (Common Stock)
2022-12-07+82,987→ 82,987 totalExercise: $1.08From: 2023-06-07Exp: 2027-12-07→ Common Stock (82,987 underlying) - Award
Common Stock
2022-12-07$1.21/sh+82,987$99,999→ 394,989 total
Footnotes (1)
- [F1]On December 6, 2022, the Registrant entered into a securities purchase agreement with Mr. Jeffrey Spragens in connection with a private placement conducted by the Registrant, pursuant to which Mr. Spragens purchased (i) an aggregate of 82,987 shares (the "Shares") of the Registrant's common stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 82,987 shares of common stock at an exercise price of $1.08, at a combined purchase price of $1.205 per share and accompanying warrant. The warrants are exercisable six months from the date of issuance and expire five years from the date of issuance.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001410620
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 9:02 AM ET
- Size
- 7.5 KB